With more than 22,000 members worldwide, the Drug Information Association (DIA) is the premier member-driven organization encompassing the full continuum of disciplines in the pharmaceutical and related industries. DIA is a nonprofit, multidisciplinary, neutral forum for sharing information that optimizes the process of drug development and lifecycle management by providing: Global and regional forums for the exchange of information, education, and training; Extensive multidisciplinary networking opportunities; Rewarding volunteer leadership experiences; and High-quality professional development opportunities. For further information on our multiple conferences, webinars, training seminars or membership information, please visit www.diahome.org.
The DIA Annual Meeting is "the event to attend" each year by biotechnology, pharmaceutical and regulatory professionals. There is no other industry meeting of its kind that can rival the breadth and depth of experience that this meeting delivers. With over 20 content-area tracks and 300 sessions, the presentations are geared to all experience levels of attendees, from R&D and regulatory leaders to professionals in specific functional areas. The DIA Annual Meeting, above all others, offers valuable professional cross-functional learning and networking experiences.
Contact:
Drug Information Association
800 Enterprise Road
Suite 200
Horsham
Pennsylvania
19044
Tel: +1 215 293 5814
Fax: +1 215 442 6199
Web: www.diahome.org
Articles by Drug Information Association
Marketing Vigilance And Gcp Regulatory Requirements
Drug Information Association Meeting
Clinical Research
Career & Professional Development
Clinical Trials In China And India
Investigational New Drug Applications (Inds)
Drug Information Association News
- Drug Information Association 42nd Annual Meeting June 18-22, 2006 »
8,000+ International Professionals From Industry, Academia, And Regulatory Agencies Convene In Philadelphia.
- DIA 2006 Annual Meeting Update »
The 42nd Annual Meeting is an event attended by pharmaceutical, biotechnology, and regulatory professionals from around the world.
- 42nd Annual Meeting Planning Continues »
Planning moves ahead for the 42nd DIA Annual Meeting, which will take place at the Pennsylvania Convention Center in Philadelphia, June 18 to 22, 2006. Charles C. Depew, PharmD (GlaxoSmithKline) will serve as the program chairperson.
- DIA Annual Meeting Information »
Ron Fitzmartin
From June 26 - 30, over 8000 professionals from all over the world will converge on Washington, DC, to participate in the DIA 41st Annual Meeting. Don't miss the chance to network with colleagues, increase your knowledge base, and visit one of the 550 companies in the exhibit hall. The DIA Annual Meeting is the industry event of the year.
- DIA Names William J. Brassington CFO »
The Drug Information Association (DIA) announces the addition of William J. Brassington, CPA to its management team as chief financial officer.
- DIA Names New Director of Volunteer and Member Services »
The Drug Information Association (DIA) announces the addition of Marlynn Orlando to its management team as director of volunteer and member services.
- DIA Announces Alliance With C-Path »
The Drug Information Association (DIA) today announced an alliance with The C-Path Institute, a non-profit organization whose purpose is to create programs in education and research to enable the safe acceleration of new medical product development.
- MHLW, PMDA, JPMA Endorse DIA's First Multi-track Workshop in Japan »
Japanese regulators Ministry of Health, Labor and Welfare (MHLW), Pharmaceuticals and Medical Devices Agency (PMDA) and the Japan Pharmaceutical Manufacturers Association (JPMA) have endorsed the Drug Information Association's (DIA) upcoming Congress on the Development and Utilisation of Pharmaceuticals.
Drug Information Meetings
- Upcoming DIA Meetings in North America »
Brief descriptions of a few of DIA's offerings in North America are listed below. Details on these meetings and the full lineup can be viewed at www.diahome.org.
Drug Information Association News
- Autumn Meeting Highlights in Europe »
Statistical Methodology in Clinical & Non Clinical R&D
- DIA, FDA and The C-Path Institute to Sponsor Workshop on Community-acquired Pneumonia »
The Drug Information Association (DIA), FDA and The C-Path Institute will sponsor Conference on Issues in Design and Analysis of Trials in Community-acquired Pneumonia (CAP) from November 16-17 at the University of Arizona in Tucson.
- DIA Presents Oncology as a Case Study »
The Drug Information Association (DIA) will host Clinical Drug Development from Strategy to Implementation November 29 to December 1 at the Sheraton Inner Harbor Hotel in Baltimore.
- DIA Workshop to Focus on Japan Pharmaceutical Development »
Attendees to learn how regulatory requirements are influenced by medical practice and Japanese culture.
- Child Safety: DIA Event to Address Hot Issues in Pediatric Clinical Trials »
The Drug Information Association (DIA) will host Ethical, Practical and Regulatory Issues in Pediatric Clinical Trials October 25- 26 at the Washington D.C. Marriott Hotel.
- Dia To Host 18th Annual Euro Meeting In Paris, March 6-8 »
DIA will host its 18th Annual EuroMeeting March 6-8, 2006 at Le Palais des Congrès in Paris. The program will address the latest developments in important European initiatives, including pediatrics, advanced therapies, the technology platform, pharmacogenomics, pharmacovigilance and risk management planning.